Portrait of Sam Carr

Sam Carr : Consultant

Sam is a member of Oxera’s Competition and Health & Pharmaceuticals teams. He has worked on a wide range of competition issues in a variety of sectors, including merger investigations by both the European Commission and the UK Competition and Markets Authority (CMA), follow-on antitrust damages, abuse of dominance cases, and market investigations. He also has experience of damages quantification in the pharmaceutical sector.

Prior to joining Oxera, Sam completed a BSc in Economics at the University of Warwick, focusing on econometrics and competition economics. Since joining, he has also completed an MSc in Economics at the University of Warwick.

Sam speaks English.

Tel: +44 (0) 1865 253065

Sam's specialisms include:

professional experience

  • Supporting a purchaser of pharmaceuticals with quantifying the damages it is claiming from a supplier as a result of an unlawful injunction (2019–)

  • Assisting a network infrastructure provider in Eastern Europe in its response to a European Commission Article 101 investigation in relation to a network sharing agreement (2019–)

  • Advising a supplier of generic medicines in its response to allegations by the CMA of illegal market sharing in the market for a particular antibiotic in the UK (2019–)

  • Advising a North American consumer goods wholesaler in its defence against a collective claim for damages resulting from antitrust infringements (2018–)

  • Advising a large financial institution in the context of an investigation by the European Commission into an alleged breach of Article 101 in the European Government Bonds market (2017–)

  • Undertaking econometric analysis for several purchasers of cathode ray tubes (CRTs) in relation to their follow-on damages claims against the global CRT cartel (2017–)


  • MSc Economics, University of Warwick, UK

  • BSc (Hons) Economics, University of Warwick, UK

Latest Insights:  Sam Carr

Back to top